Runx2 Expression: A Mesenchymal Stem Marker for Cancer

Oncology Letters - Greece
doi 10.3892/ol.2016.5182
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Asymmetric Division: A Marker for Cancer Stem Cells ?

Oncotarget
Oncology
2013English

Stem Cell-Ness: A "Magic Marker" for Cancer

Journal of Clinical Investigation
Medicine
2005English

Basal P53 Expression Is Indispensable for Mesenchymal Stem Cell Integrity

Cell Death and Differentiation
Cell BiologyMolecular Biology
2018English

miR-217 Inhibits Osteogenic Differentiation of Rat Bone Marrow-Derived Mesenchymal Stem Cells by Binding to Runx2

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2017English

Abnormal Expression of TRIB3 in Colorectal Cancer: A Novel Marker for Prognosis

British Journal of Cancer
Cancer ResearchOncology
2009English

Extracellular Superoxide Dismutase Expression in Papillary Thyroid Cancer Mesenchymal Stem/Stromal Cells Modulates Cancer Cell Growth and Migration

Scientific Reports
Multidisciplinary
2017English

Epithelial–mesenchymal Transition and Gastric Cancer Stem Cell

Tumor Biology
MedicineCancer Research
2017English

CD133 in Breast Cancer Cells: More Than a Stem Cell Marker

Journal of Oncology
Oncology
2019English

miR‑488 Negatively Regulates Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells Induced by Psoralen by Targeting Runx2

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy